Jun 29, 2026· Comment from Association for Accessible Medicines· FDA-2024-D-4388-0007
AAM comment docket No. FDA-2024-D-4388; New Clinical Investigation Exclusivity (3-Year Exclusivity) DPs: Q&A
FDANonrulemakingFDA-2024-D-4388
New Clinical Investigation Exclusivity (3-Year Exclusivity) for Drug Products: Questions and Answers; Draft Guidance for Industry; Availability
RIN
—
Last modified
Jun 30, 2026
Comment window
closed 85d ago
Association for Accessible Medicines filings
1
Activity
Association for Accessible Medicines filed 1 comment on this docket between Jun 29, 2026 and Jun 29, 2026. 0 other organizations filed here. The comment window closed 85d ago.
What Association for Accessible Medicines filed (1)
Abstract
OPEN
View on regulations.gov →Co-filers (0)
See everyone who commented →- Association for Accessible MedicinesTHIS ORG1 filing · confidence 97%